
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging is poised for success with its integrated healthcare platform, established procurement relationships, and a growing distribution network. The recently announced partnership with Imperial Imaging Technology in the Southeast region is a significant step towards wider adoption of their Nanox.ARC system and improving commercial capabilities, with potential for further agreements and increased utilization driving revenue growth. However, execution risks and the need for additional financing remain key factors to monitor.
Bears say
Nano X Imaging is facing significant risk factors in terms of clinical/regulatory, partnership and financial, commercial, legal and intellectual property, and market share risks, which could impede the success of its Nanox.ARC segment. While the company is strategically targeting lower-cost and lower-radiation alternatives to traditional CT, its success will depend on system placements, utilization rates, and reimbursement dynamics. Upcoming catalysts to monitor include system rollouts, distributor agreements, and utilization trends, as well as updates on FDA interactions and financing activity.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares